Emerging Biologics: Breaking Down Barriers with Device Companies and the FDA
January 3, 2013 3:29 pm | by Christopher Velis | Articles | CommentsMedical devices and man-made materials have achieved major advances over recent decades. However, a new drumbeat is sounding in healthcare, as the steady growth in the use of biologics in medical procedures is gaining traction. Man-made materials will always have a place in the case of acute trauma, but biologics have the potential to take over as the most effective solution for degenerative conditions.
US Trauma Device Market to Show Moderate Growth Reaching Nearly $3.8 Billion by 2016
January 13, 2012 5:30 am | News | CommentsTORONTO--(BUSINESS WIRE)--According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the United States trauma device market, will grow at a steady pace through 2016. Pricing pressures from the increasing influence of group...
Bringing Sterilization Inside
December 7, 2004 4:46 am | Steris Corporation | Product Releases | CommentsSmith & Nephew Orthopaedics, a global provider of trauma and joint replacement systems for knees, hips, and shoulders, has begun to sterilize devices in-house.


